Clinical Trial Update: E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers [Phase 2]

View source ↗

Summary

Phase 2 study of E7-targeted TCR-T cell immunotherapy for HPV-associated cancers is currently recruiting. The sponsor is Christian Hinrichs and the trial covers…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer
• Cervical Cancer
• Head and Neck Squamous Cell Carcinoma
• Oropharyngeal Cancer
• Penile Cancer
• Vaginal Cancer
• Vulvar Cancer

Drugs mentioned

• E7 TCR-T Cell Immunotherapy (E7-targeted TCR-T cells)

Snippet

Sponsor: Christian Hinrichs | Conditions: Cervical Cancer, Throat Cancer | Phase 2 | Status: RECRUITING